ClassID:

20506

A61K31/685 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Phosphorus compounds; Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin

Recent Application in this class:
#901
20110178076
2011-07-21

Medical intervention in haematological cancers

#902
20110178008
2011-07-21

Compositions for Enhancing the Production of PPAR and/or PPAR-Associated Factors

#903
20110160161
2011-06-30

Concentrated therapeutic phospholipid compositions

#904
20110152218
2011-06-23

CRYSTALLINE PHOSPHOLIPID, METHOD FOR ITS PRODUCTION AND USE IN TREATING DAMAGED TISSUE

#905
20110150968
2011-06-23

Dissolvable dietary supplement strip and methods for using the same

#906
20110144063
2011-06-16

Glycerophospholipids for the improvement of cognitive functions

#907
20110142908
2011-06-16

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

#908
20110135719
2011-06-09

PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD AND USES THEREOF

#909
20110124061
2011-05-26

Method for preparation of polyunsaturated fatty acid-containing phosphatidylserine

#910
20110110984
2011-05-12

Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds

#911
20110110972
2011-05-12

Stimulation of an immune response by enantiomers of cationic lipids

#912
20110105601
2011-05-05

COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK

#913
20110104279
2011-05-05

HEALING POWDER AND METHOD OF USE THEREOF

#914
20110104251
2011-05-05

Cosmetic composition and method for retarding hair growth

#915
20110098254
2011-04-28

COMPOSITIONS COMPRISING PHOSPHOLIPIDS

#916
20110098249
2011-04-28

Compositions and methods of treatment for alleviating premenstrual syndrome symptoms

#917
20110097350
2011-04-28

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#918
20110082098
2011-04-07

NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE

#919
20110071118
2011-03-24

Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity

#920
20110070222
2011-03-24

Therapeutic modulation of ocular surface lubrication

#921
20110065677
2011-03-17

Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity

#922
20110065673
2011-03-17

NOVEL LEUKOTRIENE RECEPTOR AGONIST

#923
20110064661
2011-03-17

NON-RADIOACTIVE PHOSPHOLIPID COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

#924
20110059902
2011-03-10

Compositions for treating dry eye disease

#925
20110059158
2011-03-10

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#926
20110045032
2011-02-24

COMPOSITION, FORMULATIONS & KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH DEHYDROEPIANDROSTERONE(S) STEROID & AN ANTI-MUSCARINIC AGENT(S)

#927
20110044944
2011-02-24

Anti-inflammatory compositions for treating brain inflammation

#928
20110034568
2011-02-10

Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

#929
20110034415
2011-02-10

WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS

#930
20110028421
2011-02-03

Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

#931
20110015154
2011-01-20

SUPPORTING ACETYLCHOLINE FUNCTION

#932
20110014270
2011-01-20

PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION INJURY AND RELATED CONDITIONS

#933
20110003775
2011-01-06

Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder

#934
20110002896
2011-01-06

METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT

#935
20100331280
2010-12-30

Modulation of the Phospholipase A2 Pathway as a Therapeutic

#936
20100329984
2010-12-30

Respiratory dispersion for metered dose inhalers comprising perforated microstructures

#937
20100316680
2010-12-16

Anti-inflammatory properties of marine lipid compositions

#938
20100311692
2010-12-09

Pharmaceutical formulation containing choline alfoscerate

#939
20100303784
2010-12-02

Preparation for the prevention and/or treatment of vascular disorders

#940
20100298273
2010-11-25

Lipid mixture for infant nutrition

#941
20100292650
2010-11-18

Methods and Related Compositions for Reduction of Fat and Skin Tightening

#942
20100292186
2010-11-18

Pharmaceutical Composition for Treatment or Prevention of Liver Cancer

#943
20100286093
2010-11-11

ANTI-INFLAMMATORY COMPOSITION CONTAINING DOCOSAHEXAENOYL LYSOPHOSPHATIDYLAMINE AS AN ACTIVE INGREDIENT

#944
20100285159
2010-11-11

Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals

#945
20100273740
2010-10-28

Phospholipids for the Treatment of Infection by Togaviruses, Herpes Viruses and Coronaviruses

#946
20100273728
2010-10-28

Formulations for the oral administration of therapeutic agents and related methods

#947
20100272823
2010-10-28

Pulmonary delivery particles comprising an active agent

#948
20100267846
2010-10-21

Molecular delivery vehicle

#949
20100267611
2010-10-21

TREATMENT OF METABOLIC DISEASE

#950
20100266678
2010-10-21

Cholesterol level lowering liposomes

#951
20100261676
2010-10-14

Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders

#952
20100247557
2010-09-30

Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 Agonist

#953
20100247454
2010-09-30

Compositions for elastogenesis and connective tissue treatment

#954
20100240741
2010-09-23

PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF APTAMERS

#955
20100239553
2010-09-23

Methods for promoting cellular health and treatment of cancer

#956
20100227792
2010-09-09

Phospholipid and protein tablets

#957
20100226910
2010-09-09

Tissue kallikrein for the treatment of diseases associated with amyloid protein

#958
20100222259
2010-09-02

Compositions for enhancing the production of PPAR and/or PPAR-associated factors

#959
20100209364
2010-08-19

Emulsified Composition

#960
20100204162
2010-08-12

Substrate reduction therapy

#961
20100203110
2010-08-12

Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production

#962
20100196586
2010-08-05

FOODSTUFF COMPOSITION TO IMPROVE DIGESTIBILITY OF FOODSTUFF LIPIDS

#963
20100190738
2010-07-29

Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

#964
20100189784
2010-07-29

Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

#965
20100184723
2010-07-22

Carbohydrate-lipid constructs and their use in preventing or treating viral infection

#966
20100183728
2010-07-22

Nanoparticle comprising rapamycin and albumin as anticancer agent

#967
20100179226
2010-07-15

Topical dosage form comprising tri-substituted glycerol compounds

#968
20100144676
2010-06-10

Oleyl phosphocholine

#969
20100137257
2010-06-03

Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds

#970
20100137252
2010-06-03

Ophthalmic composition

#971
20100136029
2010-06-03

Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies

#972
20100098749
2010-04-22

Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids

#973
20100087397
2010-04-08

Use of lipid conjugates in the treatment of conjunctivitis

#974
20100081694
2010-04-01

COMPOSITION COMPRISING AT LEAST ONE PPAR AGONIST AND A LIPID COMPONENT

#975
20100069332
2010-03-18

Lipids containing omega-3 and omega-6 fatty acids

#976
20100063006
2010-03-11

COMPOSITIONS AND METHODS TO REDUCE FAT AND RETRACT SKIN

#977
20100048515
2010-02-25

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#978
20100048514
2010-02-25

USE OF PHOSPHOLIPIDS FOR WOUND HEALING

#979
20100047330
2010-02-25

TREATMENT FOR DARK ADAPTATION

#980
20100041751
2010-02-18

Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency

#981
20100041620
2010-02-18

METHODS FOR IMPROVING FRONTAL BRAIN BIOENERGETIC METABOLISM

#982
20100035843
2010-02-11

METHODS FOR ATTENUATING ALLERGEN-INDUCED AIRWAY HYPERREACTIVITY USING CD1D DEPENDENT ANTAGONISTS

#983
20100028417
2010-02-04

USE OF SUBSTITUTED GLYCERIN DERIVATIVES FOR PRODUCING A PHARMACEUTICAL PREPARATION

#984
20100022620
2010-01-28

EPITOPE REDUCTION THERAPY

#985
20100022444
2010-01-28

COMBINATION THERAPY FOR MODULATION OF ACTIVITY AND DEVELOPMENT OF CELLS AND TISSUES

#986
20100021573
2010-01-28

COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE

#987
20100009927
2010-01-14

Anti-Inflammatory and Anti-Allergy Extracts from Nettle

#988
20100004216
2010-01-07

Medicinal lipolysis of accumulation of fat

#989
20090312287
2009-12-17

Multi-carotenoids compositions and methods

#990
20090275545
2009-11-05

Medicinal targeted local lipolysis

#991
20090269373
2009-10-29

Saposin C-DOPS: a novel anti-tumor agent

#992
20090263486
2009-10-22

Nanoparticle-stabilized capsule formulation for treatment of inflammation

#993
20090258046
2009-10-15

COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT

#994
20090252692
2009-10-08

Esterified fatty acid composition

#995
20090246196
2009-10-01

COMBINED TARGETED THERAPY FOR THE TREATMENT OF PROLIFERATIVE DISEASE

#996
20090239825
2009-09-24

Multi-carotenoids compositions and uses therefor

#997
20090233885
2009-09-17

Compositions and Methods for Fat Reduction

#998
20090221528
2009-09-03

Therapeutic micro nutrient composition for lipolysis and sclerosis

#999
20090220523
2009-09-03

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY AND NEOVASCULARIZATION CONDITIONS

#1000
20090209775
2009-08-20

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#1001
20090208581
2009-08-20

Methods for limiting spread of pulmonary infections

#1002
20090191262
2009-07-30

Use of compounds of formula A-R-Xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations

#1003
20090170816
2009-07-02

COMBINATION COMPRISING SQUALENE, A PHOSPHOLIPID AND AN OMEGA 3 FATTY ACID FOR THE TREATMENT OF CANCER

#1004
20090143339
2009-06-04

Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels

#1005
20090142419
2009-06-04

Anti-inflammatory extract and agent and method for the production thereof

#1006
20090137663
2009-05-28

Therapeutic micro nutrient composition for drug delivery

#1007
20090131373
2009-05-21

Phospholipid complexes of curcumin having improved bioavailability

#1008
20090131368
2009-05-21

MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES

#1009
20090124579
2009-05-14

Systems and Methods For Determination of Compounds for Stimulation or Inhibition of Neocalcification

#1010
20090123534
2009-05-14

Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof

#1011
20090111773
2009-04-30

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#1012
20090110756
2009-04-30

Methods and compositions related to PLUNC surfactant polypeptides

#1013
20090104283
2009-04-23

METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS

#1014
20090081179
2009-03-26

Method for reducing the severity of neurological disorders

#1015
20090074857
2009-03-19

Glycerophospholipids for the improvement of cognitive functions

#1016
20090061067
2009-03-05

METHOD FOR MAKING KRILL MEAL

#1017
20090042840
2009-02-12

Phospholipids for Use in the Treatment of an Allergic Inflammatory Condition

#1018
20090036410
2009-02-05

Structured Phospholipids

#1019
20090029950
2009-01-29

Composition for reducing the exudation of serum proteins

#1020
20090028871
2009-01-29

NOVEL USE OF LIGANDS SPECIFIC TO FEX-2 POLYPEPTIDE

#1021
20090011978
2009-01-08

Use of Surfactant Preparations for the Treatment of Surgical Adhesions

#1022
20080312583
2008-12-18

TOPICAL COMPOSITION FOR TREATING PAIN

#1023
20080311218
2008-12-18

TOPICAL COMPOSITION FOR TREATING PAIN

#1024
20080311217
2008-12-18

TOPICIAL COMPOSITION FOR TREATING PAIN

#1025
20080311167
2008-12-18

Topical composition for treating pain

#1026
20080311097
2008-12-18

Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors

#1027
20080293667
2008-11-27

Lipid analogs for combating tumors

#1028
20080275007
2008-11-06

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#1029
20080274203
2008-11-06

Bioeffective krill oil compositions

#1030
20080269111
2008-10-30

Method of treating dyslipidemic disorder

#1031
20080261865
2008-10-23

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#1032
20080260680
2008-10-23

Method of Attenuating Reactions to Skin Irritants

#1033
20080254017
2008-10-16

Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids

#1034
20080248129
2008-10-09

Compounds and methods for promoting cellular health and treatment of cancer

#1035
20080241233
2008-10-02

TARGETED DELIVERY AND EXPRESSION OF PROCOAGULANT HEMOSTATIC ACTIVITY

#1036
20080233194
2008-09-25

Dispersion for pulmonary delivery of a bioactive agent

#1037
20080227726
2008-09-18

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#1038
20080226564
2008-09-18

Respiratory dispersion for metered dose inhalers

#1039
20080207503
2008-08-28

Composition and Treatment Methods for Coronary Artery Disease

#1040
20080193561
2008-08-14

Preparation for the prevention and/or treatment of vascular disorders

#1041
20080193394
2008-08-14

Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine

#1042
20080187511
2008-08-07

OINTMENT FOR CANCER TREATMENT

#1043
20080176935
2008-07-24

Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals

#1044
20080166401
2008-07-10

Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids

#1045
20080160098
2008-07-03

USE OF SIMPLE AMINO ACIDS TO FORM POROUS PARTICLES

#1046
20080160092
2008-07-03

USE OF SIMPLE AMINO ACIDS TO FORM POROUS PARTICLES

#1047
20080160074
2008-07-03

PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES

#1048
20080153782
2008-06-26

Use of lecithin as a medication for the treatment of psoriasis

#1049
20080152726
2008-06-26

Method for reducing the severity of neurological disorders

#1050
20080152585
2008-06-26

Low viscosity liquid dosage forms

#1051
20080145902
2008-06-19

METHOD FOR PREPARATION OF POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHATIDYLSERINE

#1052
20080139973
2008-06-12

Particle Enhancement Agent For High Intensity Focused Ultrasound Treatment And Use Thereof

#1053
20080138290
2008-06-12

Fluoro-Carbon Emulsion Enhancement Agent for High Intensity Focused Ultrasound Treatment and Use thereof

#1054
20080132472
2008-06-05

Compounds for the treatment of psychiatric or substance abuse disorders

#1055
20080124386
2008-05-29

APOPTOSIS-MIMICKING SYNTHETIC ENTITIES AND USE THEREOF IN MEDICAL TREATMENT

#1056
20080113935
2008-05-15

Use of lipid conjugates in the treatment of diseases or disorders of the eye

#1057
20080113002
2008-05-15

Contact lens compositions

#1058
20080108548
2008-05-08

Food Composition For Rapidly Attenuating Inflammatory Responses

#1059
20080090781
2008-04-17

Formulations containing alkylphosphocholines using novel negative charge carriers

#1060
20080085320
2008-04-10

Lipids containing omega-3 and omega-6 fatty acids

#1061
20080085319
2008-04-10

LIPIDS CONTAINING OMEGA-3 AND OMEGA-6 FATTY ACIDS

#1062
20080075764
2008-03-27

PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES

#1063
20080064635
2008-03-13

Infant Formulas for Early Brain Development

#1064
20080058286
2008-03-06

Novel applications of omega-3 rich phospholipids

#1065
20080044487
2008-02-21

Anti-inflammatory properties of marine lipid compositions

#1066
20080021000
2008-01-24

MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES

#1067
20080019926
2008-01-24

Lung Surfactant Supplements

#1068
20080004266
2008-01-03

Method for treating proliferative disorders with HSP90 inhibitors

#1069
20080003330
2008-01-03

Infant formulas for early brain development

#1070
20080003244
2008-01-03

Inflammation and Oxidative Stress Reducing Compostion for Topical or Oral Administration

#1071
20070298097
2007-12-27

MULTI-CAROTENOIDS COMPOSITIONS AND USES THEREFOR

#1072
20070292536
2007-12-20

COMPOSITION AND METHOD FOR TREATING PATIENTS WITH HIGH NEUROTRANSMITTER LEVELS

#1073
20070265196
2007-11-15

Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein

#1074
20070264206
2007-11-15

Mucosal formulation

#1075
20070253934
2007-11-01

Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it

#1076
20070243268
2007-10-18

Compositions for regulating intestinal disorders and methods of use thereof

#1077
20070243211
2007-10-18

Compositions for regulating metabolic disorders and methods of use thereof

#1078
20070237786
2007-10-11

Diet supplement for causing rapid weight loss, controlling appetite, managing stress, supporting relaxation, combating fatigue and supporting mental well-being.

#1079
20070224256
2007-09-27

Apoptosis-mimicking synthetic entities and use thereof in medical treatment

#1080
20070212405
2007-09-13

Dispersion for pulmonary delivery of a bioactive agent

#1081
20070202194
2007-08-30

Preparation for the prevention and/or treatment of vascular disorders

#1082
20070197644
2007-08-23

Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia

#1083
20070197442
2007-08-23

Methods for the Treatment of Macular Degeneration and Related Eye Conditions

#1084
20070196914
2007-08-23

Methods for preparing oil bodies comprising active ingredients

#1085
20070190064
2007-08-16

Enteral composition for the prevention and/or treatment of sepis

#1086
20070160659
2007-07-12

Stabilized formulations of phosphatidylserine

#1087
20070157331
2007-07-05

Protection of female reproductive system from natural and artifical insults

#1088
20070155700
2007-07-05

Use of lipid conjugates in the treatment of conjunctivitis

#1089
20070148168
2007-06-28

Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions

#1090
20070135382
2007-06-14

Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions

#1091
20070135376
2007-06-14

METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY

#1092
20070129297
2007-06-07

Treatment and prevention of asthma

#1093
20070111969
2007-05-17

Pharmaceutical compositions for the administration of aptamers

#1094
20070111953
2007-05-17

Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease

#1095
20070110827
2007-05-17

Pharmaceutical compositions for the administration of aptamers

#1096
20070110775
2007-05-17

Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same

#1097
20070105812
2007-05-10

Lipid analogs for inhibiting HIV-1 activity

#1098
20070105811
2007-05-10

Lipid analogs for inhibiting the activity of hepatitis B antigen

#1099
20070104658
2007-05-10

Use of simple amino acids to form porous particles

#1100
20070099870
2007-05-03

Lipid analogs for combating tumors

#1101
20070099868
2007-05-03

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#1102
20070098808
2007-05-03

Krill extracts for treatment of cardiovascular diseases

#1103
20070087009
2007-04-19

Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist

#1104
20070082017
2007-04-12

Lipid compositions and methods of use

#1105
20070078111
2007-04-05

LPA2 receptor agonist inhibitors of CFTR

#1106
20070078107
2007-04-05

Use of lipid conjugates in the treatment of disease

#1107
20070071805
2007-03-29

Treatment of inflammation and vascular abnormalities of the eye

#1108
20070066567
2007-03-22

Use of phospholipid arachidonic acids for increasing muscle mass in humans

#1109
20070060648
2007-03-15

Lipids from methanotrophic bacteria for cholesterol reduction

#1110
20070060548
2007-03-15

Modulation of Epac, phospholipase Cepsilon, and phospholipase D to treat pain

#1111
20070049554
2007-03-01

Method for treatment or prevention of conditions caused by gram-positive bacteria

#1112
20070042998
2007-02-22

Medical cosmetic method for reducing adipose tissue and for initiating lipolysis through subcutaneous and intracutaneous injections and customized composition compounded from pharmaceutical agents for use therein

#1113
20070042008
2007-02-22

Compositions containing phosphatidylcholine and essential fatty acids

#1114
20070037777
2007-02-15

Lipid-containing compositions and methods of using them

#1115
20070036849
2007-02-15

Use of phospholipid arachidonic acids for increasing muscle mass in humans

#1116
20070036737
2007-02-15

PRODUCTS FOR TOPICAL APPLICATION COMPRISING LYSOPHOSPHOLIPIDS AND FATTY ACIDS

#1117
20070031480
2007-02-08

Enhanced delivery of sphingolipids

#1118
20070026024
2007-02-01

Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant

#1119
20070015795
2007-01-18

Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities

#1120
20070015686
2007-01-18

Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells

#1121
20070010429
2007-01-11

Phospholipid formulations and uses thereof in lung disease detection and treatment

#1122
20070009608
2007-01-11

Composition comprising plant and/or fish oils and compounds comprising non-oxidizable fatty acid entities

#1123
20070009590
2007-01-11

Physiologically active composition based on phosphatidylserine

#1124
20070004678
2007-01-04

Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes

#1125
20070004639
2007-01-04

Methods and compositions for treating Parkinson's disease

#1126
20060293276
2006-12-28

Use of lipid conjugates in the treatment of disease

#1127
20060286183
2006-12-21

Diet supplement for causing rapid weight loss, controlling appetite, managing stress, supporting relaxation, combating fatigue and supporting mental well-being

#1128
20060286181
2006-12-21

Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism

#1129
20060286038
2006-12-21

Pulmonary surfactant formulations

#1130
20060275356
2006-12-07

Pharmaceutical compositions for treating or preventing coronary artery disease

#1131
20060270631
2006-11-30

Methods for the treatment and prevention of angiogenic diseases

#1132
20060270630
2006-11-30

Methods for the treatment and prevention of inflammatory diseases

#1133
20060263376
2006-11-23

Pharmaceutical composition comprising PIM-activated NKT cells, and use thereof in therapy

#1134
20060258624
2006-11-16

Composition and method for reducing the appearance of cellulite

#1135
20060258623
2006-11-16

Absorption of fat-soluble nutrients

#1136
20060257502
2006-11-16

A COMBINATION OF MITOCHONDRIAL NUTRIENTS FOR RELIEVING STRESS, PREVENTING AND IMPROVING STRESS-RELATED DISORDERS

#1137
20060246124
2006-11-02

Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally

#1138
20060241080
2006-10-26

Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions

#1139
20060228395
2006-10-12

Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage

#1140
20060222673
2006-10-05

INJECTABLE PHOSPHATIDYLCHOLINE PREPARATIONS

#1141
20060222639
2006-10-05

Wound treatment utilizing collagenase and a phosphotidylcholine organogel

#1142
20060217312
2006-09-28

Charged lipoprotein complexes and their uses

#1143
20060210546
2006-09-21

Athlete dietary supplement

#1144
20060205815
2006-09-14

Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition

#1145
20060194765
2006-08-31

Methods and compositions using oxidized phospholipids

#1146
20060172939
2006-08-03

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#1147
20060171956
2006-08-03

Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination

#1148
20060171946
2006-08-03

Compositions and methods for the treatment and prevention of hyperproliferative diseases

#1149
20060166935
2006-07-27

Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction

#1150
20060166934
2006-07-27

Composition comprising phytosphingosine derivatives for apoptosis induction

#1151
20060165771
2006-07-27

Compositions for delivery of drug combinations

#1152
20060165606
2006-07-27

Pulmonary delivery particles comprising water insoluble or crystalline active agents

#1153
20060160721
2006-07-20

Method of plasma lipidation to prevent, inhibit and/or reverse atherosclerosis

#1154
20060159629
2006-07-20

Pulmonary delivery particles with phospholipid structural matrix

#1155
20060148776
2006-07-06

Drug formulations having long and medium chain triglycerides

#1156
20060148761
2006-07-06

Lipids

#1157
20060134244
2006-06-22

Breast health supplement and detoxification preparations

#1158
20060134090
2006-06-22

Method and dietary composition for improving lipid digestibility

#1159
20060128656
2006-06-15

Charged phospholipid compositions and methods for their use

#1160
20060127468
2006-06-15

Methods and related compositions for reduction of fat and skin tightening

#1161
20060116355
2006-06-01

Eye care kit for treating periocular disease

#1162
20060105032
2006-05-18

Multiple sclerosis treatment

#1163
20060100146
2006-05-11

AWAT-related methods and articles

#1164
20060078574
2006-04-13

Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same

#1165
20060078560
2006-04-13

Method of inducing apoptosis and inhibiting cardiolipin synthesis

#1166
20060069061
2006-03-30

Compositions containing uridine and choline, and methods utilizing same

#1167
20060063738
2006-03-23

Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof

#1168
20060051385
2006-03-09

Cationic antiseptic compositions and methods of use

#1169
20060029685
2006-02-09

Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals

#1170
20060025376
2006-02-02

Uridine effects on dopamine release

#1171
20060024277
2006-02-02

Method of skin care and/or treatment using extracts enriched in mitochondria

#1172
20060019870
2006-01-26

Apoprotein cochleate compositions

#1173
20060013905
2006-01-19

Anti-inflammatory compositions for treating multiple sclerosis

#1174
20060013903
2006-01-19

Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss

#1175
20050288255
2005-12-29

Modulation of lysophosphatidylcholine and treatment of diet-induced conditions

#1176
20050288254
2005-12-29

Therapeutic use of agonist ligands specific to G2A receptor

#1177
20050287199
2005-12-29

Therapeutic micro nutrient composition for lipolysis and drug delivery

#1178
20050287180
2005-12-29

Phospholipid compositions and methods for their preparation and use

#1179
20050282750
2005-12-22

Treatment for dark adaptation

#1180
20050272813
2005-12-08

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#1181
20050267212
2005-12-01

Omega-3 fatty acids in the treatment of depression

#1182
20050267080
2005-12-01

Methods and related compositions for reduction of fat

#1183
20050249783
2005-11-10

Method of improving absorption of vitamin E by a pet animal

#1184
20050244510
2005-11-03

Compositions for improving mental performance

#1185
20050220860
2005-10-06

Stabilized pure vitamin-C in powder to liquid form using multi-encapsulation method

#1186
20050215524
2005-09-29

Methods and compositions for improving photodynamic therapy through administration of lipids

#1187
20050209170
2005-09-22

Breast health preparations

#1188
20050209152
2005-09-22

Polypeptoid pulmonary surfactants

#1189
20050208162
2005-09-22

Esterified fatty acid composition

#1190
20050208150
2005-09-22

Compositions for elastogenesis and connective tissue treatment

#1191
20050203053
2005-09-15

Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function

#1192
20050187192
2005-08-25

Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses

#1193
20050187191
2005-08-25

Methods and compositions for the treatment of respiratory syncytial virus

#1194
20050187186
2005-08-25

Pharmaceutical compositions of safingol and methods of using the same

#1195
20050187182
2005-08-25

Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function

#1196
20050182026
2005-08-18

Use of phospholipids in peritoneal dialysis

#1197
20050176676
2005-08-11

Uridine administration stimulates membrane production

#1198
20050158835
2005-07-21

Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid

#1199
20050147660
2005-07-07

Peptide-carrying bodies for immune response

#1200
20050147649
2005-07-07

Method and dietary composition for improving fat digestibility